---
figid: PMC9117958__etm-23-06-11341-g02
pmcid: PMC9117958
image_filename: etm-23-06-11341-g02.jpg
figure_link: /pmc/articles/PMC9117958/figure/f3-ETM-0-0-11341/
number: Figure 3
figure_title: ''
caption: RV treatment decreases serum levels of inflammatory cytokines in atherosclerosis
  model mice. (A and B) Effects of RV treatment on the serum levels of (A) TNF-α and
  (B) CRP compared with the control. (C) Effects of RV treatment on MMP-9 and CD40L
  expression levels in arterial lesion tissue compared with the control. Scale bars,
  25 µm. *P<0.05 and **P<0.01. RV, resveratrol; TNF-α, tumor necrosis factor-α; CRP,
  c-reactive protein; MMP-9, matrix metalloproteinase-9.
article_title: Resveratrol protects against atherosclerosis by downregulating the
  PI3K/AKT/mTOR signaling pathway in atherosclerosis model mice.
citation: Wuguang Ji, et al. Exp Ther Med. 2022 Jun;23(6):414.
year: '2022'

doi: 10.3892/etm.2022.11341
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- resveratrol
- atherosclerosis
- inflammation
- PI3K
- AKT
- mTOR

---
